Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Discover various work from home opportunities that can provide you with fast money. These options cater to different skills and schedules.
19,997 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Kentucky lawmakers are advancing a consumer-protection bill tied to crypto kiosks that could force hardware wallet pr...
A bold market prediction centers on Nvidia stock rising 150% by 2028—but only if a single, enduring driver keeps AI s...
israel’s stock market, which surged at the outbreak of the conflict with Iran, has returned to pre-war levels as inve...
Apple reports strong Q2 2026 results, led by iPhone demand and Services, while signaling a shift toward ambient AI th...
Apple sits around $284 as traders weigh the next move. A robust quarter and expanding Services set the stage for a bu...
The SEC outlines a two-stage approach to on-chain trading, echoing lessons from the 1990s as it weighs how crypto ven...
A landmark federal lawsuit against OpenAI puts AI liability in the spotlight. This article explains what it means for...
Chip stocks pause after a blistering run, with Intel crashing 10%, slides as investors take profits and reassess AI m...
Rad Intel is sprinting toward a final fundraising window as it pitches an AI-powered platform designed to curb the ri...
Barclays and Mizuho boost Alibaba's price target to $195 after the Cloud Intelligence Group posts 38% yearly growth, ...
Nvidia is poised to deliver another strong earnings quarter, but history shows a big print doesn’t always move the st...